非典型的脂质瘤的管理算法:一个回顾性的案例系列
Muhammad Umair1, Maria Mahmood1, Adeel Zafar1
1Department of Surgery, Tallaght University Hospital, Dublin, IRL.
Cureus
|February 13, 2025
概括
非典型的脂质瘤 (ALT) 经常被错误命名,低估了复发风险. 这项研究提出了一种管理算法,以区分ALT和脂瘤,帮助患者的护理和风险分层.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 病理学 病理学 病理学
背景情况:
- 非典型的脂质瘤 (ALT),也称为低度良好分化的脂质瘤 (WDLs),由于复杂的放射和组织学特征,存在诊断挑战.
- 目前对ALT的分类可能低估了他们局部复发的潜力,需要明确的管理策略.
研究的目的:
- 评估非典型的脂质瘤的临床,放射和组织学特征.
- 开发和提出一种管理算法,以区分ALT与良性脂瘤.
主要方法:
- 从塔拉格特大学医院 (2013-2019) 进行前性维护数据库的回顾性分析.
- 包括非典型的脂质瘤患者,详细介绍人口统计,瘤特征,放射学发现,治疗和复发数据.
主要成果:
- 在607个切除的脂质瘤中,37名患者的40个病变被归类为ALT.
- ALT患者的平均年龄为56.15岁,下肢是最常见的位置.
- 三名患者 (7.5%) 经历了需要重新手术的局部复发;两名患者 (5%) 需要手术前的血管栓塞.
结论:
- 区分非典型的脂质瘤与脂质瘤对于适当的患者管理至关重要.
- 磁力共振成像 (MRI) 发现,包括增加的内瘤血管性和隔离,可能表明脂细胞瘤的恶性潜力.
- 提出的管理算法可以帮助分层皮下病变.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.7K
相关概念视频
Chronic Pancreatitis II: Collaborative Care
572
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
572
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
